Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000635386 | SCV000756796 | likely benign | GNE myopathy; Sialuria | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004691980 | SCV005195421 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001829785 | SCV002075615 | uncertain significance | GNE myopathy | 2019-10-28 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004748874 | SCV005356436 | likely benign | GNE-related disorder | 2024-05-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |